Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer
This study is ongoing, but not recruiting participants.
Study NCT00002968 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: June 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
edrecolomab
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Monoclonal antibody 17-1A
More general drug interventions related to this trial
Antineoplastic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Southwest Oncology Group
Eastern Cooperative Oncology Group
North Central Cancer Treatment Group
European Organization for Research and Treatment of Cancer
NCIC Clinical Trials Group
Back to top of Main Content
